Definition of DOTATATE. Meaning of DOTATATE. Synonyms of DOTATATE

Here you will find one or more explanations in English for the word DOTATATE. Also in the bottom left of the page several parts of wikipedia pages related to the word DOTATATE and, of course, DOTATATE synonyms and on the right images related to the word DOTATATE.

Definition of DOTATATE

No result for DOTATATE. Showing similar results...

Meaning of DOTATATE from wikipedia

- DOTA-TATE (DOTATATE, DOTA-octreotate, oxodotreotide, DOTA-(Tyr3)-octreotate, and DOTA-0-Tyr3-Octreotate) is an eight amino acid long peptide, with a covalently...
- oxodotreotide (INN) or 177Lu dotatate, brand name Lutathera, is a chelated complex of a radioisotope of the element lutetium with dotatate, used in peptide receptor...
- therapy. In June 2016, Netspot (kit for the preparation of gallium Ga-68 dotatate injection) was approved for medical use in the United States. In August...
- Copper (64Cu) oxodotreotide or Copper Cu 64 dotatate, sold under the brand name Detectnet, is a radioactive diagnostic agent indicated for use with positron...
- 177Lu-DOTATATE product, has been quoted by the manufacturer as £71,500 (€80,000 or $94,000 in July 2018) for 4 administrations of 7.4 GBq. 177Lu-DOTATATE (international...
- acid (DOTA). Attached to the dotatate is the radioactive marker Lu-177, a radioisotope. The dotatate binds to the GEP-NET positive somatostatin...
- scan is now being replaced in most centers with gallium-68 DOTATATE and copper-64 DOTATATE scans. Somatostatin receptor imaging can now be performed with...
- pheochromocytomas, which however are chromaffin-positive.[citation needed] Gallium-68 DOTATATE PET/CT imaging modality may be used to confirm the presence of a paraganglioma...
- mentioned above in the functional imaging section. Treatment with 177Lu-DOTATATE first demonstrated success in patients with undifferentiated neuroendocrine...
- Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine Tumors NCT04494113 Testing the Response to the Anti-cancer...